Europe Heparin Market

Heparin Market (Product - Low Molecular Weight Heparin, Unfractionated Heparin, Ultra-low Molecular Weight Heparin; End Applications - Hospitals, Blood and Stem Cell Bank ) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • Rep Id : TMRGL4815
  • Published On : Aug 2016
  • No. of Pages : 101
  • Category : Pharmaceutical

1. Preface
    1.1. Research Scope
    1.2. Market Segmentation
    1.3. Research Objectives
    1.4. Key Questions Answered

2. Assumptions and Research Methodology
    2.1. Report Assumptions
    2.2. Acronyms Used
    2.3. Research Methodology

3. Executive Summary
    3.1. Europe Heparin Market Snapshot
    3.2. Key Trends

4. Market Overview
    4.1. Product Overview
    4.2. Key Industry Events
    4.3. Death Rate of CVD in Europe, 2015
    4.4. Top Causes of Death in the EU
    4.5. Pharmaceutical Expenditure, 2014
    4.6. Pharmaceutical Expenditure, 2013

5. Market Dynamics
    5.1. Drivers and Restraints Snapshot Analysis
    5.2. Drivers
          5.2.1. Rise in incidence of coagulation and renal disorders in Europe
          5.2.2. Inclination of slaughterhouse owners to enter crude heparin processing business expected to overcome demand-supply gap
          5.2.3. Ban on imports from China to boost production in Europe
          5.2.4. Commercialization of safe and cost-effective heparin products
    5.3. Restraints
          5.3.1. Availability of alternative anticoagulants impeding sale of biological heparin products
          5.3.2. Enhanced quality control measures and environmental factors elevating the cost of heparin production
          5.3.3. Patent loss and increasing use of off-label products
          5.3.4. Risk of heparin induced thrombocytopenia
    5.4. Opportunities
          5.4.1. Biosimilars as an alternative to biological-based products
          5.4.2. Research activities on marine-based heparin products
    5.5. Opportunity Analysis
    5.6. Pricing and Market Projections

6. Europe Heparin Market Analysis, by Product Type
    6.1. Key Findings
    6.2. Market Value Share Analysis, by Product Type, 2015 and 2024
    6.3. Europe Heparin Market Size (US$ Mn) Forecast, by Product, 2014-2024
          6.3.1.  Low Molecular Weight Heparin
          6.3.2. Unfractionated Heparin
          6.3.3. Ultra-low Molecular Weight Heparin
    6.4. Key Trends
    6.5. Market Attractiveness Analysis, by Product, 2015

7. Europe Heparin Market Analysis, by End-user
    7.1. Key Findings
    7.2. Introduction
    7.3. Market Value Share Analysis, by End-user, 2015 and 2024
    7.4. Europe Heparin Market Size (US$ Mn) Forecast, by End-user, 2014-2024
          7.4.1. Hospitals
          7.4.2. Blood and Stem Cell Bank
          7.4.3. Others
    7.5. Key Trends

8. Europe Heparin Market Analysis, by Country
    8.1. Market Value Share Analysis, by Country, 2015 and 2024
    8.2. Germany
    8.3. France
    8.4. U.K.
    8.5. Italy
    8.6. Spain
    8.7. Poland
    8.8. Switzerland
    8.9. Austria
    8.10. Hungary
    8.11. Belgium
    8.12. Portugal
    8.13. Czech Republic
    8.14. Greece
    8.15. Slovakia
    8.16. Rest of Europe
    8.17. Market Attractiveness Analysis, by End-user, 2015

9. Competitive Landscape
    9.1. Europe Heparin Market Share Analysis, by Company (2015)
    9.2. Competition Matrix
          9.2.1. Sanofi SA
          9.2.2. GlaxoSmithKline plc
          9.2.3. Pfizer, Inc.
          9.2.4. Leo Pharma
          9.2.5. Dr. Reddy’s Laboratories
          9.2.6. Fresenius SE & Co. KG
          9.2.7. Teva Pharmaceutical Industries Ltd.

10. Company Profiles
    10.1. Sanofi SA
          10.1.1. Company Details
          10.1.2. Company Description
          10.1.3. Business Overview
          10.1.4. SWOT Analysis
          10.1.5. Financial Analysis
          10.1.6. Strategic Overview
    10.2. GlaxoSmithKline plc
          10.2.1. Company Details
          10.2.2. Company Description
          10.2.3. Business Overview
          10.2.4. SWOT Analysis
          10.2.5. Financial Analysis
          10.2.6. Strategic Overview
    10.3. Pfizer, Inc. 
          10.3.1. Company Details
          10.3.2. Company Description
          10.3.3. Business Overview
          10.3.4. SWOT Analysis
          10.3.5. Financial Analysis
          10.3.6. Strategic Overview
    10.4. Leo Pharma
          10.4.1. Company Details
          10.4.2. Company Description
          10.4.3. Business Overview
          10.4.4. SWOT Analysis
          10.4.5. Financial Analysis
          10.4.6. Strategic Overview
    10.5. Dr. Reddy’s Laboratories
          10.5.1. Company Details
          10.5.2. Company Description
          10.5.3. Business Overview
          10.5.4. SWOT Analysis
          10.5.5. Financial Analysis
          10.5.6. Strategic Overview
    10.6. Fresenius SE & Co. KG
          10.6.1. Company Details
          10.6.2. Company Description
          10.6.3. Business Overview
          10.6.4. SWOT Analysis
          10.6.5. Financial Analysis
          10.6.6. Strategic Overview
    10.7. Teva Pharmaceutical Industries Ltd. 
          10.7.1. Company Details
          10.7.2. Company Description
          10.7.3. Business Overview
          10.7.4. SWOT Analysis
          10.7.5. Financial Analysis
          10.7.6. Strategic Overview

 

List of Tables

TABLE 1 Europe Heparin Market Size (US$ Mn) Forecast, By Product, 2016–2024
TABLE 2 Europe Heparin Market Size (US$ Mn) Forecast, By End-user, 2016–2024
TABLE 3 Europe Heparin Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Figures

FIG. 1 Europe Heparin Market Revenue (US$ Mn), 2015
FIG. 2 Europe Heparin Market Size (US$ Mn) Forecast, 2014–2024
FIG. 3 Europe Heparin Average Pricing Analysis (US$) 2015–2024
FIG. 4 Europe Heparin Market Value Share Analysis By Product, 2016 and 2024
FIG. 5 Europe LMWH Market Revenue, (US$ Mn), 2014-2024
FIG. 6 Europe Unfractionated Heparin Market Revenue (US$ Mn), 2014-2024
FIG. 7 Europe ULMWH Market Revenue, (US$ Mn), 2014-2024
FIG. 8 Europe Heparin Market Value Share Analysis By End-user, 2016 and 2024
FIG. 9 Europe Hospitals Heparin Market Revenue, (US$ Mn), 2014–2024
FIG. 10 Europe Blood and Stem Cell Bank Heparin Market Revenue, (US$ Mn), 2014-2024
FIG. 11 Europe Others (End-user) Heparin Market Revenue, (US$ Mn), 2014–2024
FIG. 12 Europe Heparin Market Value Share Analysis, by Country, 2015 and 2024
FIG. 13 Germany Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 14 France Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 15 UK Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 16 Italy Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 17 Spain Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 18 Poland Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 19 Switzerland Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 20 Austria Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 21 Hungary Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 22 Belgium Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 23 Portugal Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 24 Czech Republic Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 25 Greece Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 26 Slovakia Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 27 Rest of Europe Heparin Market Revenue (US$ Mn), 2014–2024
FIG. 28 Heparin Market Attractiveness Analysis, by Product, 2015
FIG. 29 Heparin Market Attractiveness Analysis, by End-user, 2015
FIG. 30 Europe Heparin Market Share Analysis By Company (2015)